Celltrion holdings Nasdaq

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

Viva Republica Inc., a leading South Korean fintech unicorn and operator of mobile financial super app Toss, has dropped its plan to go public in th...

South Korea's Daesang Corp. said on Monday it hosted the "Jongga Kimchi Blast" event in the US to promote kimchi and elevate Korean food culture.&...

POSCO Holdings Inc. said on Sunday it completed a lithium hydroxide plant in Argentina, boosting its capacity to produce electric vehicle (EV) batte...

Seoul will light up Myeong-dong, a bustling area with office workers and shoppers in the heart of the city, with 16 large outdoor digital billboards...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...

North Asia-focused private equity firm MBK Partners Ltd. has secured a large enough stake in Korea Zinc Inc. through a tender offer to take control ...

Lotte Shopping Co., South Korea’s leading retail company, will transform its special purpose company (SPC) in Singapore into a holding firm to...

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

South Korea will be included in a global major bond index next year to attract an estimated $66 billion in capital inflows to Asia’s fourth-la...

Nearly half of South Korean startups hold negative views on the country’s startup ecosystem, citing the prolonged startup funding winter and t...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....

Within just two hours of the opening of the 13th Seoul Record Fair last Saturday, the waitlist for new LP records reached 1,500. There were 20 new r...

The Asan Nanum Foundation announced on Wednesday that it will hold a demo day for “The Chung Ju-yung Startup Competition” on Nov. 7 at C...

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...

South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...

South Korea’s leading retailers, including Coupang Inc., are ramping up their logistics capacities to counter aggressive forays into the count...

South Korea's Lotte Group holds "2024 Korea Shopping Festa with Lotte" in Hanoi, Vietnam. The group and the Korean Ministry of SMEs and Startup...

South Korea’s central bank held interest rates steady but cut its inflation and growth forecasts for the year and signaled that it will pivot ...

Yanolja Co., South Korea’s leading travel and accommodation booking platform operator, may delay its Nasdaq initial public offering plan due t...

Samyang Roundsquare, the holding company of South Korea's Samyang Group, said on Friday that it recruits foreign interns with the potential for full...

Korea Investment Management Co. said on Thursday that the net assets of its ACE US Nasdaq 100 Exchange-Traded Fund (ETF) had surpassed 1 trillion wo...

EcoPro BM Co., a South Korean cathode materials producer, said on Tuesday it has signed a memorandum of understanding (MOU) with GEM, a Chinese batt...

Foreigner-only casino operators in South Korea reported weaker-than-expected operating profit in the second quarter as prolific gamblers traveling f...

South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...

Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, has decided to separate its non-core units to concentrate on the defen...

South Korea’s top travel and accommodation booking platform operator Yanolja Co. is seeking to streamline and restructure its affiliates to bo...

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...